Proinflammatory cell stress in sporadic inclusion body myositis muscle: Overexpression of αB-crystallin is associated with amyloid precursor protein and accumulation of β-amyloid

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 12, 2009, Pages 1344-1349

  Muth, I E ^a   Barthel, K ^a   Bahr M ^a   Dalakas, M C ^b   Schmidt, J ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; DESMIN; GAMMA INTERFERON; INTERLEUKIN 1BETA; NERVE CELL ADHESION MOLECULE;

ARTICLE; CELL INFILTRATION; CELL STRESS; CELL VACUOLE; CELLULAR STRESS RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCLUSION BODY MYOSITIS; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MUSCLE BIOPSY; MUSCLE CELL; NERVE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ALPHA-CRYSTALLIN B CHAIN; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; CELLS, CULTURED; DESMIN; HUMANS; INFLAMMATION; MUSCLE FIBERS, SKELETAL; MYOSITIS, INCLUSION BODY; NEURAL CELL ADHESION MOLECULES; STRESS, PHYSIOLOGICAL; UBIQUITIN;

EID: 72449199088     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.174276     Document Type: Article

References (18)

1. Dalakas MC. Sporadic inclusion body myositis - diagnosis, pathogenesis and therapeutic strategies. Nat Clin Pract Neurol 2006;2:437-447
2. Needham M, Corbett A, Day T, et al. Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis. J Clin Neurosci 2008;15:1350-1353
3. Griggs RC. The current status of treatment for inclusion-body myositis. Neurology 2006;66:S30-2.
4. Askanas V, Engel WK. Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition. Neurology 2006;66:S39-48.
5. Schmidt J, Barthel K, Wrede A, et al. Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle. Brain 2008;131:1228-1240
6. Askanas V, McFerrin J, Baque S, et al. Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. Proc Natl Acad Sci U S A 1996;93:1314-1319 (Pubitemid 26052886)
7. Kitazawa M, Green KN, Caccamo A, et al. Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice. Am J Pathol 2006;168:1986-1997 (Pubitemid 43825318)
8. Sugarman MC, Yamasaki TR, Oddo S, et al. Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle. Proc Natl Acad Sci U S A 2002;99:6334-6339 (Pubitemid 34493312)
9. Askanas V, Engel WK. Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis. Curr Opin Rheumatol 2007;19:550-559 (Pubitemid 47530874)
10. Banwell BL, Engel AG. Alpha B-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology 2000;54:1033-1041
11. Goldfarb LG, Vicart P, Goebel HH, et al. Desmin myopathy. Brain 2004;127:723-734
12. Fonte V, Kipp DR, Yerg J, et al. Suppression of in vivo beta-amyloid peptide toxicity by overexpression of the HSP-16.2 small chaperone protein. J Biol Chem 2008;283:784-791
13. Wilhelmus MM, Boelens WC, Otte-Holler I, et al. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity. Brain Res 2006;1089:67-78. (Pubitemid 43786300)
14. Ousman SS, Tomooka BH, van Noort JM, et al. Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Nature 2007;448:474-479
15. Wojcik S, Engel WK, McFerrin J, et al. AbetaPP-overexpression and proteasome inhibition increase alphaB-crystallin in cultured human muscle: relevance to inclusion-body myositis. Neuromuscul Disord 2006;16:839-844 (Pubitemid 44855597)
16. Kitazawa M, Trinh DN, LaFerla FM. Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta. Ann Neurol 2008;64:15-24.
17. Ferrer I, Martin B, Castano JG, et al. Proteasornal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis. J Neuropathol Exp Neurol 2004;63:484-498 (Pubitemid 38669669)
18. Fischer D, Matten J, Reimann J, et al. Expression, localization and functional divergence of alphaB-crystallin and heat shock protein 27 in core myopathies and neurogenic atrophy. Acta Neuropathol 2002;104:297-304. (Pubitemid 36075391)